Daniel Barber - 09 Mar 2023 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
President and CEO
Signature
/s/ Lori Braender, as Attorney-In-Fact
Issuer symbol
AQST
Transactions as of
09 Mar 2023
Transactions value $
$0
Form type
4
Filing time
09 Mar 2023, 14:06:57 UTC
Previous filing
08 Aug 2022
Next filing
05 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AQST Common Stock Award $0 +447,000 +231% $0.000000 640,702 09 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.